These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27200494)

  • 1. Performance on a computerized neurocognitive battery in 22q11.2 deletion syndrome: A comparison between US and Israeli cohorts.
    Yi JJ; Weinberger R; Moore TM; Calkins ME; Guri Y; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RE; Gothelf D; Gur RC
    Brain Cogn; 2016 Jul; 106():33-41. PubMed ID: 27200494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
    Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities.
    Gur RE; Yi JJ; McDonald-McGinn DM; Tang SX; Calkins ME; Whinna D; Souders MC; Savitt A; Zackai EH; Moberg PJ; Emanuel BS; Gur RC
    Mol Psychiatry; 2014 Nov; 19(11):1205-11. PubMed ID: 24445907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Musical auditory processing, cognition, and psychopathology in 22q11.2 deletion syndrome.
    Gao L; Tang SX; Yi JJ; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Calkins ME; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):765-773. PubMed ID: 30444066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct neurocognitive profiles and clinical phenotypes associated with copy number variation at the 22q11.2 locus.
    O'Hora KP; Kushan-Wells L; Schleifer CH; Cruz S; Hoftman GD; Jalbrzikowski M; Gur RE; Gur RC; Bearden CE
    Autism Res; 2023 Dec; 16(12):2247-2262. PubMed ID: 37997544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of psychiatric comorbidity and cognitive deficit on function in 22q11.2 deletion syndrome.
    Yi JJ; Calkins ME; Tang SX; Kohler CG; McDonald-McGinn DM; Zackai EH; Savitt AP; Bilker WB; Whinna DA; Souders MC; Emanuel BS; Gur RC; Gur RE
    J Clin Psychiatry; 2015 Oct; 76(10):e1262-70. PubMed ID: 26528648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social cognition dysfunction in adolescents with 22q11.2 deletion syndrome (velo-cardio-facial syndrome): relationship with executive functioning and social competence/functioning.
    Campbell LE; McCabe KL; Melville JL; Strutt PA; Schall U
    J Intellect Disabil Res; 2015 Sep; 59(9):845-59. PubMed ID: 25726953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining cognitive speed and accuracy dysfunction in youth and young adults with pediatric-onset multiple sclerosis using a computerized neurocognitive battery.
    Barlow-Krelina E; Fabri TL; O'Mahony J; Gur RC; Gur RE; De Somma E; Bolongaita L; Dunn CL; Bacchus M; Yeh EA; Marrie RA; Bar-Or A; Banwell BL; Till C
    Neuropsychology; 2021 May; 35(4):388-398. PubMed ID: 34043389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis.
    Goldenberg PC; Calkins ME; Richard J; McDonald-McGinn D; Zackai E; Mitra N; Emanuel B; Devoto M; Borgmann-Winter K; Kohler C; Conroy CG; Gur RC; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jan; 159B(1):87-93. PubMed ID: 22170773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive profiles of 22q11.2 and 16p11.2 deletions and duplications.
    Gur RC; Bearden CE; Jacquemont S; Swillen A; van Amelsvoort T; van den Bree M; Vorstman J; Sebat J; Ruparel K; Gallagher RS; McClellan E; White L; Crowley TB; Giunta V; Kushan L; O'Hora K; Verbesselt J; Vandensande A; Vingerhoets C; van Haelst M; Hall J; Harwood J; Chawner SJRA; Patel N; Palad K; Hong O; Guevara J; Martin CO; Jizi K; Bélanger AM; Scherer SW; Bassett AS; McDonald-McGinn DM; Gur RE
    Mol Psychiatry; 2024 Jul; ():. PubMed ID: 39048645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between reaction time, fine motor control, and visual-spatial perception on vigilance and visual-motor tasks in 22q11.2 Deletion Syndrome.
    Howley SA; Prasad SE; Pender NP; Murphy KC
    Res Dev Disabil; 2012; 33(5):1495-502. PubMed ID: 22522207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive Functioning in Patients with 22q11.2 Deletion Syndrome: A Meta-Analytic Review.
    Moberg PJ; Richman MJ; Roalf DR; Morse CL; Graefe AC; Brennan L; Vickers K; Tsering W; Kamath V; Turetsky BI; Gur RC; Gur RE
    Behav Genet; 2018 Jul; 48(4):259-270. PubMed ID: 29922984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory deficits and psychosis-spectrum symptoms in 22q11.2 deletion syndrome.
    Tang SX; Moberg PJ; Yi JJ; Wiemken AS; Dress EM; Moore TM; Calkins ME; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE; Turetsky BI
    Schizophr Res; 2018 Dec; 202():113-119. PubMed ID: 30007867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Neurocognition in Youth with CKD Using a Novel Computerized Neurocognitive Battery.
    Hartung EA; Kim JY; Laney N; Hooper SR; Radcliffe J; Port AM; Gur RC; Furth SL
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):39-46. PubMed ID: 26500247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Neurocognitive Profiles and Clinical Phenotypes Associated with Copy Number Variation at the 22q11.2 Locus.
    O'Hora KP; Kushan-Wells L; Hoftman GD; Jalbrzikowski M; Gur RC; Gur R; Bearden CE
    medRxiv; 2023 May; ():. PubMed ID: 37292882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia.
    Fiksinski AM; Breetvelt EJ; Lee YJ; Boot E; Butcher N; Palmer L; Chow EWC; Kahn RS; Vorstman JAS; Bassett AS
    Psychol Med; 2019 Apr; 49(6):1047-1054. PubMed ID: 30064532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome.
    Hooper SR; Curtiss K; Schoch K; Keshavan MS; Allen A; Shashi V
    Res Dev Disabil; 2013 May; 34(5):1758-69. PubMed ID: 23506790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.